Israeli Startups and German SMEs - Medical Technology

The digital health sector is prospering in Israel. With over 550 innovative companies, technology hubs, R&D centers, incubators and multiantional corporations in this space, the vibrant Israeli digital health ecosystem has more than doubled in size since 2011. Within this ecosystem, approximately 40% of digital health companies utilize Artificial Intelligence in thei solutions.

This virtual event gives German SMEs a short overview of the Israeli digital health sector. Furthermore, four Startups will present their innovations, products and services to the audience. The Subsectors minimal invasive surgery, remote monitoring and digital therapeutics are mainly represented in the pitches of the Startups.

This event ist powered by global connect. The second event of this series deals with cyber security and takes place on the 20th of october at 3 pm.

Die Registrierung ist leider bereits geschlossen. Für Rückfragen nehmen Sie bitte Kontakt mit uns auf.









Israeli Startups and German SMEs - Medical Technology

July 13, 2021 / 3:00 - 4:15PM (CEST)

Israeli ecosystem of the digital health sector

Israel has more than 25 years of accumulated data in its healthcare system, 98% of which is digitized. In early 2018, the Isareli government approved a budget of over $300M to support digital health as the next economic growth engine. Among its goals are financial incentives to encourage collaborations between Israeli technologies and foreign healthcare systems.
Digital therapeutics is the largest subsector of the Israeli digital health sector, with 138 companies, followed by remote monitoring, with 109 companies. Other subsectors are decision support, clinical workflow, diagnostics, patient engagement and assistive devices.
Within the ecosystem, approximately 40% of digital health companies utilize Artificial Intelligence in their solutions. Furthermore, 75% of digital health companies that raised fundes in 2019 were AI-driven companies, and most of the AI-driven companies are in the field of decision support, which provides essential tools for healthcare providers in numerous settings.


IHK Reutlingen and IHK Stuttgart

Charme Rykower, Senior Executive, Innovations- & Cooperationscout Baden Württemberg, AHK Israel

Yoav Fisher, Head of Technological Innovation and Digital Health, HealthIL

David Messer, VP Business Development

ScoutCam develops and manufactures customized visual solutions in the form of highly resistant micro-cameras and supplementary technologies. The cameras are as small as 1 millimeter in diameter including illumination.

The company's high-resolution technology has been authenticated by customers such as NASA in strict environmental conditions including extreme temperatures, vibrations, and radiation.

ScoutCam is a wholly owned subsidiary of Medigus.

Shay Hershcovich, Co-Founder and Marketing Manager

Betalin Therapeutics seeks to eliminate the need for insulin injections and glucose testing in diabetes patients with its proprietary transplanted Engineered Micro Pancreas (EMP). The EMP technology helps create connective tissue that enables the body's beta cells to function properly and produce adequate and functional insulin.

Betalin Therapeutics licensed the novel EMP technology developed at the Hebrew University of Jerusalem, Israel, in an exclusive worldwide agreement in 2015. The Hebrew University continues to partner with Betalin Therapeutics to support the research and development.

Sonovia produces a sono-fishing technology, which is scientifically proven to provide active protection against viruses, bacteria and funghi at over 99% efficacy.

Michael Hirsh, Director for Business Development

Neteera is focused on bridging the gap between the analog and digital worlds by enabling seamless, continuous, and contact-free monitoring of human vital signs.

Neteera’s micro-radar-on-chip and proprietary algorithms can detect microscopic skin motions through clothing. This takes place at a very high frequency, allowing for noninvasive, seamless, continuous monitoring of human vital signs such as heart and respiration rates, heart rate variability, inhale–exhale ratio, and tidal volume, and many more features under development.

The company’s technology is non-vision-based (camera-free) and the company ensures that all information obtained is completely anonymized, providing ultimate privacy. Collected data is stored in the Neteera HIPAA- and GDPR-compliant cloud for further analysis, EMR/EHR integration, and future decision support mechanisms.

Neteera’s technology is is clinically validated with an FDA 510(k) Class I exemption and a 510(k) Class II planned in 2021. The company is globally recognized as disruptive and innovative and was ranked 9th out of 1,350 companies in CNBC’s 2020 Disruptor 50 list.

Roni Zidon, Vice President of Business Development

AceTech develops precision medicine technology for the prediction of adverse effects and prescription products for their prevention and management. A privately owned, vertically integrated (from plantation to final product) biotechnology company, AceTech executes transitional research to create precision medicine solutions and develop biopharmaceutical Rx and OTC products targeting the skin and dental care markets.

The company uses biomedical sensors, artificial intelligence, big data algorithms, and microbiome profiling to collect, connect, and analyze big data measurements and create an individual skin signature which is then translated into a personalized prescription and recommendations. Its prescription products are designed to provide a four-R solution: The Right patient, with the Right product, at the Right dose, and on the Right schedule for its prevention and management.

Q&A Session